Chemical Structure (Isosorbide 01)
Isosorbide Dinitrate And Hydralazine Hydrochloride Tablet, Film Coated
Product Images NDC 72162-2343
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Isosorbide Dinitrate And Hydralazine Hydrochloride (NDC 72162-2343). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Isosorbide 02)
Figure 1 (Isosorbide 03)
This is a Kaplan-Meier plot displaying the Time to Death by All Cause in Black Patients for the A-HeFT study. The plot shows a 43% reduction in mortality for patients treated with BiDil compared to those who received a placebo. The statistical significance of this difference was determined to be P=0.012 using the Log-Rank Test. The x-axis represents time in days, while the y-axis shows the proportion of patients surviving at each time point.*
Figure 2 (Isosorbide 04)
Figure 2 represents a Kaplan-Meier plot showing the Time to First Hospitalization for Heart Failure in Black Patients from the A-HeFT study. The graph indicates a notable 39% risk reduction in the occurrence of first hospitalization for heart failure among the treatment group compared to the placebo group. The statistical significance of this reduction is emphasized by a P-value of less than 0.001 from the Log-Rank Test. The plot displays time in days on the x-axis and the cumulative event rate on the y-axis, showing a clear divergence between the treatment and placebo groups over time.*
Figure 3 (Isosorbide 05)
Figure 4 (Isosorbide 06)
Label (Lbl721622343)
This text describes a medication containing 20 mg isosorbide dinitrate and 37.5 mg hydralazine HCI per tablet. It advises keeping the medication out of reach of children and storing it at room temperature. The usual dosage information is available in the package insert found on a specific website. The tablet is available in a bottle containing 90 tablets, and it is manufactured by Lannett Company, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
